Tag Archives: san francisco

BIO Investor Forum Celebrates 15th Year with Record Number of Partnering Meetings

bio-4

The 15th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all prior years’ numbers of meetings arranged through the BIO One-on-One Partnering™ system. Both the conference and the partnering system are designed to help investors identify the latest trends and provide biotech innovators an opportunity to secure the funding necessary to bring their technologies to market. This year’s forum brought together over 880 attendees including 240 investors and 155 presenting companies. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Does Big Company M&A Impact Small Company M&A?

bif-logo

Over the last few years, we have seen significant consolidation among the large drug manufacturers, with both franchise swapping and mergers of equals – but what is the impact on small biotechs? At the BIO Investor Forum, (held at the Westin St. Francis in San Francisco today), a panel session moderated by Matthew Hudes, Chief Executive Officer of bdlBiologx, set out to answer that very question. The panelists, all seasoned industry veterans, came from a Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Post-election Scenarios to Microbiome Therapies—Diverse Panels at 2016 BIO Investor Forum

us_flag

Government policy and regulation, investment trends, latest discoveries, drug development, licensing and other topics will be covered during panel sessions at the 15th annual BIO Investor Forum Oct 18-19 in San Francisco. Among the varied educational topics covered during the conference is one that can only occur every four years: the presidential election. The presidential campaign is generating interest from all sectors of American society—and rightfully so. The decision made in November will impact all Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Plan Now to Attend the 15th Annual BIO Investor Forum Oct 18-19, San Francisco

The BIO Investor Forum, now in its 15th year, is open for registration. An international conference with plenary sessions, business roundtables, company presentations, therapeutic workshops, networking opportunities and partnering meetings, it is designed to help early-stage companies find sources of capital. Attendees will have opportunities to learn about the latest investment trends as well as showcase their company to qualified investors. BIO is pleased to announce that Rachel Haurwitz, PhD, CEO of Caribou Biosciences, will Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Value of Lifesaving Medicines: How Best To Define and Communicate The Innovations In Biopharmaceuticals

image-1

One of BIO’s central goals is to promote the value of innovation in lifesaving medicines and what that means for the public at-large. At Day 1 of the BIO International Convention in San Francisco, attendees gathered to hear more about how best to communicate this vital mission. “Defining and Communication Medical Innovation Value for the Long Term” was moderated by Al Jackson, of Spectrum Science Communications and featured panelists Lambert van der Walde of UnitedHealth Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,